Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution

LH Lin, U Ozerdem, P Cotzia, J Lee, J Chun… - Human pathology, 2021 - Elsevier
The management of intraductal papilloma (IDP) diagnosed on core needle biopsy (CNB) is
controversial due to the variable upgrade rates to breast carcinoma (BC) on subsequent …

Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors

H Corbin, P Bomeisl, AL Amin, HN Marshall, H Gilmore… - Human Pathology, 2022 - Elsevier
Surgical excision of breast intraductal papilloma (IDP) without atypia diagnosed on core
needle biopsy (CNB) is controversial as the risk of upgrade to malignant lesions is not well …

Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: a clinical, radiological and pathological correlation study

IS Genco, B Tugertimur, PA Manolas… - The American Journal of …, 2020 - Elsevier
Background The aim of the study was to determine the upgrade rate on excision of
intraductal papilloma (IDP) without atypia diagnosed on breast core needle biopsy (CNB) …

Upgrade rate and predictive factors for breast benign intraductal papilloma diagnosed at biopsy: a meta-analysis

X Zhang, W Liu, T Hai, F Li - Annals of Surgical Oncology, 2021 - Springer
Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …

[PDF][PDF] Benign intraductal papilloma without atypia on core needle biopsy has a low rate of upgrading to malignancy after excision

SH Han, M Kim, YR Chung, B La Yun… - Journal of breast …, 2018 - synapse.koreamed.org
Purpose: The management of benign intraductal papilloma (IDP) without atypia diagnosed
on core needle biopsy (CNB) remains controversial. This study was performed to evaluate …

[HTML][HTML] Audit on intraductal papilloma of the breast: upgrade rate, management pitfalls, and updated guidelines in a Tertiary Health Care Center

H Esmayil, S Abayazeed, M Hajaj - Cureus, 2021 - ncbi.nlm.nih.gov
Background Intraductal papillomas (IDPs) are typically classified as B3 lesions in histology
as they may show intralesional heterogeneity with a potential upgrade to malignancy. On …

Breast cancer risk associated with benign intraductal papillomas initially diagnosed on core needle biopsy

L Nasehi, CD Sturgis, N Sharma, P Turk… - Clinical Breast …, 2018 - Elsevier
Background The long-term risk for patients with benign intraductal papillomas (IDPs) on core
needle biopsy (CNB) who are not upgraded on excision is not well-defined. The goal of this …

Multidisciplinary review of intraductal papilloma of the breast can identify patients who may omit surgical excision

S Abbassi-Rahbar, S Sack, KE Larson… - Annals of Surgical …, 2021 - Springer
Background The purpose of this study was to define contemporary management
recommendations regarding who would benefit from surgical excision of intraductal …

Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy

M Rizzo, MJ Lund, G Oprea, M Schniederjan… - Annals of surgical …, 2008 - Springer
Background The clinical management of breast intraductal papilloma (IDP) remains
controversial. The objective of this study was to survey a large cohort of benign IDP …

Breast intraductal papillomas without atypia in radiologic‐pathologic concordant core‐needle biopsies: rate of upgrade to carcinoma at excision

F Pareja, AD Corben, SB Brennan, MP Murray… - Cancer, 2016 - Wiley Online Library
BACKGROUND The surgical management of mammary intraductal papilloma without atypia
(IDP) identified at core‐needle biopsy (CNB) is controversial. This study assessed the rate of …